Myths vs facts: COMT and Abnehmen

The claim that the COMT genotype directly determines weight loss success is a myth often exaggerated in direct-to-consumer genetic test marketing. Fact: COMT (catechol-O-methyltransferase) degrades dopamine and other catecholamines. The common rs4680 (Val158Met) variant alters enzyme activity – the Met variant is slower, leading to higher dopamine levels. Some studies suggest links to appetite regulation and energy expenditure, but effect sizes are small, inconsistent, and heavily confounded by lifestyle factors (diet, exercise, stress). There is no robust evidence that a COMT genotype alone can guide personalized diet or exercise plans for weight loss. Most commercial tests oversimplify the polygenic nature of body weight regulation (hundreds of genes with tiny effects). Moreover, the provided context contains no direct evidence on COMT and weight loss. Therefore, be cautious of overblown promises. A COMT test may serve as a minor puzzle piece, not a decision tool. Evidence: mixed, based on mechanistic and small human studies, but insufficient for clinical recommendations.